| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008451239 |
| P356 | DOI | 10.2165/00003495-200059003-00001 |
| P698 | PubMed publication ID | 10845408 |
| P2093 | author name string | Leggett JE | |
| P2860 | cites work | Intravenous antibiotic therapy in an outpatient setting | Q34278448 |
| Determinants of efficacy and toxicity of aminoglycosides | Q34510814 | ||
| Intramuscular ceftriaxone in home parenteral therapy | Q35564146 | ||
| Continuous infusion of beta-lactam antibiotics | Q35656806 | ||
| Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients | Q35814807 | ||
| Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis | Q35867013 | ||
| Practice guidelines for community-based parenteral anti-infective therapy. ISDA Practice Guidelines Committee | Q38555438 | ||
| Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance | Q39828366 | ||
| Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA | Q40432517 | ||
| Outpatient treatment of endocarditis in a clinic-based program in Argentina | Q40432521 | ||
| Experience with a physician-directed, clinic-based program for outpatient parenteral antibiotic therapy in the USA | Q40432529 | ||
| Use of teicoplanin in community medicine | Q40584161 | ||
| Management of infective complications in patients with advanced hematologic malignancies in home care | Q40644849 | ||
| Outpatient antibiotic therapy for febrile episodes in low-risk neutropenic patients with cancer | Q40658433 | ||
| A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia | Q40668231 | ||
| Ambulatory treatment with ceftriaxone in febrile neutropenic children. | Q40697602 | ||
| Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man. | Q40827402 | ||
| Evolution of outpatient parenteral antibiotic therapy | Q40828902 | ||
| Adverse reactions following intravenous penicillin-G relate to degradation of the drug in vitro | Q40829828 | ||
| Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Selecting the antibiotic | Q40913641 | ||
| Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Advances in i.v. delivery | Q40913644 | ||
| Pharmacokinetics and pharmacodynamics of antibiotics in otitis media | Q41148314 | ||
| Outpatient intravenous antibiotic therapy. Ten years' experience | Q41391973 | ||
| Oral administration of antibiotics: a rational alternative to the parenteral route | Q41440909 | ||
| Outpatient parenteral antimicrobial-drug therapy | Q41593943 | ||
| Penicillin dosing for pneumococcal pneumonia | Q41665610 | ||
| Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials | Q42671287 | ||
| Efficacy and safety of intravenous cefotaxime for treating pneumonia in outpatients | Q43589387 | ||
| Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
| Role for Dual Individualization with Cefmenoxime | Q44806786 | ||
| Treatment of skin and soft-tissue infections utilizing an outpatient parenteral drug delivery device: a multicenter trial. HIAT Study Group | Q45087973 | ||
| Ambulatory antibiotic infusion devices: extending the spectrum of outpatient therapies | Q46735540 | ||
| Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects. | Q52525472 | ||
| Intramuscular meropenem in the treatment of bacterial infections of the urinary and lower respiratory tracts. Italian Intramuscular Meropenem Study Group. | Q54005702 | ||
| Secondary bacterial infections in HIV-infected patients: an alternative ambulatory outpatient treatment utilizing intravenous cefotaxime. | Q54025202 | ||
| Choosing an antibiotic on the basis of pharmacodynamics. | Q54130813 | ||
| Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis | Q54169300 | ||
| Postantibiotic leukocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes | Q67294880 | ||
| Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility | Q67717640 | ||
| Ceftriaxone Sodium Therapy of Penicillin G—Susceptible Streptococcal Endocarditis | Q67717654 | ||
| Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis | Q68178250 | ||
| Home intravenous antibiotic therapy using a programmable infusion pump | Q69607833 | ||
| Cefonicid in a once-daily regimen for treatment of osteomyelitis in an ambulatory setting | Q70514538 | ||
| Safety, efficacy, and cost savings in an outpatient intravenous antibiotic program | Q70622990 | ||
| Home intravenous anti-infective therapy (HIVAT): do the benefits outweigh the risks? | Q71273778 | ||
| Reducing costs and hospital stay for pneumonia with home intravenous cefotaxime treatment: results with a computerized ambulatory drug delivery system | Q72127789 | ||
| Combined ceftriaxone and surgical therapy for osteomyelitis in hospital and outpatient settings | Q72395760 | ||
| Outpatient use of ceftriaxone: a cost-benefit analysis | Q72400050 | ||
| Effect of storage of penicillin-G solutions on sensitisation to penicillin-G after intravenous administration | Q72526258 | ||
| Home versus hospital intravenous antibiotic therapy in the treatment of young adults with cystic fibrosis | Q72894833 | ||
| Outpatient antimicrobial protocol for febrile neutropenia: a nonrandomized prospective trial using ceftriaxone, amikacin, and oral adjuvant agents | Q73419787 | ||
| Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: clinical outcome, microbiology and pharmacokinetics | Q73568583 | ||
| The pharmacodynamics of beta-lactams | Q74802265 | ||
| A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate | Q77348001 | ||
| Home-based treatment of cellulitis with twice-daily cefazolin | Q77713445 | ||
| Patient selection in outpatient parenteral antimicrobial therapy | Q77793512 | ||
| Pharmacokinetics and pharmacodynamics of outpatient intravenous antimicrobial therapy | Q77793516 | ||
| Outpatient parenteral antimicrobial therapy for osteomyelitis | Q77793530 | ||
| Practice guidelines for community-based parenteral anti-infective therapy | Q77793567 | ||
| P304 | page(s) | 1-8; discussion 47-9 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Ambulatory use of parenteral antibacterials: contemporary perspectives | |
| P478 | volume | 59 Suppl 3 |
| Q26829316 | Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines |
| Q43672860 | Ambulatory parenteral antimicrobial therapies. Five-year experience |
| Q31058008 | Intravenous antimicrobial therapy in the hospital-at-home setting: data from the Spanish Outpatient Parenteral Antimicrobial Therapy Registry. |
| Q35163896 | Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy |
| Q37807783 | Pediatric outpatient parenteral antimicrobial therapy: an update |
Search more.